Literature DB >> 27192515

Incidence of allergic contact sensitization in central Chinese subjects with chronic urticaria.

Hao Chen1, Guanghui Liu1, Nan Huang1, Wenjing Li1, Xiang Dong1, Rongfei Zhu1.   

Abstract

BACKGROUND: Chronic urticaria (CU) can be provoked by a wide variety of causes. Some studies suggest contact sensitization may play a role in the disease.
OBJECTIVE: To investigate the incidence and distribution characteristics of allergic contact sensitization in central Chinese subjects with CU, and assess contact allergen avoidance measures in managing CU.
METHODS: Patch tests were performed, following the recommended standard procedure, with 20 selected allergens, in line with the European baseline series. All subjects with positive results were prescribed appropriate avoidance measures for the sensitizing substances, while subjects with negative results served as the control group. CU severity was assessed daily from week1 to week4 and for each subject, applying the Urticaria Activity Score.
RESULTS: 42.9% (233/543) of subjects with CU showed positive reactions to one or more contact allergen(s). Potassium dichromate, benzene mix and carba mix were more common in male patients, while nickel sulfate was more frequent in females. The positive rates for different allergens varied with age and occupation. The median (interquartile range) severity scores at week 1 were 20 (14-21) and 15 (14-27) for the allergen avoidance group and control group, respectively (P>0.05); and 12 (7-15) and 14 (12-17) at week 4 (P<0.001).
CONCLUSION: The incidence of allergic contact sensitization in CU patients was high, and appropriate contact allergen avoidance measures benefitted CU management. Contact allergens may play a role in the pathogenic mechanism of CU and patch tests are an option for CU patients.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27192515      PMCID: PMC4861563          DOI: 10.1590/abd1806-4841.20164606

Source DB:  PubMed          Journal:  An Bras Dermatol        ISSN: 0365-0596            Impact factor:   1.896


INTRODUCTION

Urticaria is a frequent, mast cell-driven disease, presenting with wheals, angioedema or both. The lifetime prevalence for acute urticaria is approximately 20% and up to 80% of acute urticaria cases are due to allergenic triggers.[1] Recurrent urticaria lasting over 6 weeks is clinically defined as chronic urticaria (CU), which causes a decrease in quality of life and affects academic and professional performance.[2] Multifactorial etiologies including autoimmune processes, intolerance to food or drugs and infectious diseases have been proved to play roles in CU’s pathogenesis.[3-5] Etiology is essential to the management of CU. However, in most CU patients, no exogenous cause is determined even after a detailed diagnostic procedure, and the condition is termed chronic idiopathic urticaria, leading to symptomatic pharmacological treatment, usually antihistamines.[6] Thus, symptoms always relapse rapidly after discontinuance of medications. Although guidelines do not recommend patch testing for contact sensitization in CU patients, some studies have suggested contact sensitization may contribute to the pathogenic mechanism of CU.[7-8] Our study sought to investigate the incidence and distribution characteristics of allergic contact sensitization in central Chinese subjects with CU, and assess contact allergen avoidance measures in managing CU.

METHODS

Patient inclusion and exclusion. CU patients from central China were included in our study at Tongji Hospital, Wuhan, between January 2011 and January 2012. Exclusion criteria were the following: (i) inducible urticaria such as dermographism, cold urticaria, delayed pressure urticaria, heat urticaria, cholinergic urticaria, etc; (ii) urticaria related to other autoimmune disorders; (iii) abnormal results to routine laboratory measures, including differential blood count, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP); (iv) symptoms relieved after omission of suspected factors suggested by history, such as drugs and foods; (v) patients with positive reactions to autologous serum skin tests (ASST). All subjects gave written informed consent and approval was obtained from Tongji hospital ethics committees. Patch test procedure. Patch tests were performed at the first visit with 20 contact allergens from a new European baseline series (IQ Chamber System, Sweden), and each patient was instructed not to bathe, exercise or take drugs like antihistamines or systemic steroids, during the test period. All patches were uncovered carefully one hour after initial application, examining signs of contact urticaria to exclude acute urticaria. Strips were removed 48 hours later, while reactions were checked 72 hours later. Results were evaluated in accordance with the standard scoring system recommended by the International Contact Dermatitis Research Group guidelines.[9] Contact allergen avoidance. Once contact allergen sensitization was diagnosed, patients were informed about how to avoid the revealed allergens, with detailed oral and written instructions (e.g. for nickel sensitization, patients were instructed to avoid contact with nickel items and adopt a low-nickel diet). Symptom assessment and treatment. Urticaria severity was assessed via the UAS, a unified and simple scoring system to evaluate the symptom (pruritus) and sign (wheal) from 0 (none) to 3 (intense).[9] UAS7 is the aggregate score for seven consecutive days, ranging from 0 to 42. For each patient, UAS scores were recorded for 4 weeks following receipt of patch test results. Patients were prescribed loratadine or cetirizine 10mg daily, but systemic steroids and immunomodulator were forbidden during our study period. Statistical analysis. Continuous measures were expressed as means ± standard deviations for normally distributed data, and medians and percentiles for non-normally distributed data. Descriptive statistics was used to describe demographic data. Pearson’s chisquared tests and Fisher’s exact tests were employed to evaluate the categorical variables. Non-parametric (Mann-Whitney U) tests were performed to assess comparability of UAS scores between the allergen avoidance group and control group. A P value of under 0.05 was considered statistically significant. All data were analyzed using the SPSS software, version 17.0.

RESULTS

Demographic data. Of the 543 patients in this study, 165 (30.39%) were male and 378 (69.61%) were female. Their ages ranged from 5 to 85 years, with a median age of 39 years (interquartile range, 27-48). Positive rates for patch tests in CU. Two hundred and thirty-three patients (42.9%) had positive reactions to the contact allergens. Positive rates for each contact allergen are displayed in table 1.
Table 1

Positive rates for contact allergens in 543 CU patients

AllergenPositive reaction rate
n%
Cobalt chloride346.26
Mercapto mix30.55
Imidazolidinyl urea20.37
p-Phenylenediamine142.58
N-cyclohexyl-ylthio71.29
phthalocyanine lactone  
Potassium dichromate5710.5
Ethylenediamine81.47
dihydrochloride  
Colopony101.84
Formaldehyde356.45
Epoxy resin40.74
Bronopol81.47
Thiuram mix20.37
Benzene mix183.31
Nickel sulfate417.55
Sesquiterpene lactone mix112.03
Fragrance mix407.37
Cl+Me-Isothiazole183.31
Black rubber mix30.55
Carba mix549.94
Quaternium-1561.1
Positive rates for contact allergens in 543 CU patients Among these patients, 146 (62.66%) had a positive reaction to one allergen, 55 (23.61%) to two allergens, 21 (9.01%) to three allergens, 6 (2.58%) to four allergens, and only 5 (2.14%) to five or more allergens. Frequency of contact allergens. Potassium dichromate was the most common sensitizer (10.5%, n=57), followed by carba mix (9.94%, n=54), nickel sulfate (7.55%, n=41), fragrance mix (7.37%, n=40), formaldehyde (6.45%, n=35) and cobalt chloride (6.26%, n=34) (Table 1). Contact sensitization profile between genders. Positive reactions to nickel sulfate were more common among women than men (9.26% vs. 3.64%, P=0.023), while positive reactions to potassium dichromate, benzene mix, and carba mix were more frequent among men than women (14.55% vs. 8.73%, P=0.042; 6.67% vs. 1.85%, P=0.004; 18.79% vs. 6.08%, P<0.001). There was no statistically significant difference between genders regarding other allergens (Table 2).
Table 2

Contact sensitization profile among different genders, age groups and occupations

AllergensGender Age Occupation
MF ChAdYoMiEl OWTSFaMSCWSpUE
165378 153018527241 11313034423631157
 Percentage (%)
Cobalt chloride6.676.08 0.003.338.656.250.00 11.50*6.150.007.148.339.682.55
Mercapto mix0.000.79 0.000.000.001.100.00 0.000.000.000.000.000.001.91
Imidazolidinyl urea0.000.53 0.000.000.000.372.44 0.000.000.000.000.000.001.27
p-Phenylenediamine2.422.65 0.000.000.004.414.88 1.770.005.880.005.566.453.82
N-cyclohexyl-ylthio phthalocyanine lactone2.420.79 0.000.000.541.474.88 0.880.772.940.002.780.001.91
Potassium dichromate14.55*8.73 0.006.6711.3512.500.00 17.705.3817.659.5219.44**0.008.28
Ethylenediamine dihydrochloride0.611.85 0.000.001.621.104.88 1.770.000.002.380.003.232.55
Colopony1.212.12 0.000.000.543.310.00 3.540.000.000.002.783.232.55
Formaldehyde4.247.41 0.000.004.329.93*0.00 8.854.620.000.0013.8912.906.37
Epoxy resin1.210.53 0.000.000.540.374.88* 0.000.000.000.005.560.001.27
Bronopol1.821.32 0.000.001.621.840.00 1.770.0011.76**0.000.000.001.27
Thiuram mix1.210.00 0.000.000.000.372.44 0.000.002.940.002.780.000.00
Benzene mix6.67**1.85 26.673.332.702.940.00 2.655.380.004.768.330.001.91
Nickel sulfate3.649.26* 0.003.3311.356.622.44 9.734.6211.760.0011.1116.137.01
Sesquiterpene lactone mix1.212.38 0.003.331.622.212.44 0.002.310.004.765.566.451.27
Fragrance mix6.067.94 6.670.004.868.0919.51* 6.190.7732.35**4.7611.1112.907.01
Cl+Me-Isothiazole1.823.97 0.003.331.624.414.88 4.422.310.004.762.780.004.46
Black rubber mix1.210.26 6.670.000.000.372.44 0.001.540.000.002.780.000.00
Carba mix18.79**6.08 0.006.6711.358.4619.51 10.628.4614.7111.9019.440.008.92
Quaternium-151.211.06 0.000.001.620.742.44 1.770.000.000.005.560.001.27

P<0.05;

P<0.01.

M, male; F, female; Ch, children (≤14 years); Ad, adolescence(15-18 years); Yo, youth (19-35 years); Mi, middle-aged (36-60 years); El, elderly (>60 years); OW, office worker; TS, teacher or student; Fa, farmer; MS, medical staff; CW, construction worker; Sp, spinner; UE, unemployed.

Contact sensitization profile among different genders, age groups and occupations P<0.05; P<0.01. M, male; F, female; Ch, children (≤14 years); Ad, adolescence(15-18 years); Yo, youth (19-35 years); Mi, middle-aged (36-60 years); El, elderly (>60 years); OW, office worker; TS, teacher or student; Fa, farmer; MS, medical staff; CW, construction worker; Sp, spinner; UE, unemployed. Contact sensitization among different age groups. Formaldehyde was a common allergen in middle-aged patients (9.93%) (P=0.013), while the positive rate for epoxy resin was higher in elderly patients (4.88%) (P=0.004). Fragrance mix sensitivity was more frequent in elderly patients (19.51%) than juvenile (4.86%) (P=0.001) and middle-aged (8.08%) ones (P=0.021) (Table 2). Contact sensitization among different occupations. Positive reaction rates were as follows: cobalt chloride in office workers (11.50%, P=0.009), potassium dichromate in construction workers (19.44%, P=0.038), and bronopol and fragrance mix in farmers (11.76% and 32.35%, P=0.023 and 0.017) (Table 2). Allergen avoidance and symptoms score. In week 1, the median (interquartile range) severity scores were 20 (14-21) and 15(14-27) in the allergen avoidance group and control group, respectively (P>0.05). In week 4, the scores were 12 (7-15) and 14 (12-17), respectively (P<0.001) (Figure 1).
Figure 1

The comparison of UAS scores between allergen avoidance group and control group

The comparison of UAS scores between allergen avoidance group and control group

DISCUSSION

Worldwide CU prevalence has been estimated to range from 0.5% to 5%.10 CU severely affects patients’ quality of life and can cause disability and distress.[11] However, the cause or pathogenic mechanism of CU cannot be identified in many patients, and symptoms always relapse when symptomatic pharmacological treatments are discontinued. Patch testing is an important diagnostic tool for identifying the responsible allergens in allergic contact dermatitis (ACD), and the incidence of contact sensitization has been well documented. [12] According to current guidelines, patch testing is not recommended for CU. However, in several studies, the prevalence of contact sensitization in CU was high and avoidance measures resulted in remission of symptoms, implying that allergic contact sensitization may play a role in the pathogenic mechanism of CU6.[7,8] In China, patch testing is not routinely performed for CU. We focused on the incidence and distribution characteristics of allergic contact sensitization in central Chinese subjects with CU, and sought to assess contact allergen avoidance measures in managing CU. In our study, 42.9% (233/543) of subjects exhibited positive reactions to one or more allergens, which was similar to results in Italy (41%)[7] but lower than those of a previous study conducted in northern China (52.4%).[13] These studies suggested that almost half of the CU patients had contact sensitization. However, given the lack of well-designed intervention studies, previous reports could not determine definitively whether these sensitizations were relevant. Allergic contact sensitization is known to be influenced by environmental, cultural, occupational, individual, genetic, racial or ethnic factors, which may explain why the rates of positive reactions to each allergen vary across different regions and countries. For example, nickel was the most common contact allergen in Italian CU patients; metals and fragrances were still the most frequent allergens across Europe.7 In our study, the most frequent allergen was potassium dichromate (10.5%), mostly from cement, perhaps due to the nationwide infrastructure investment programs, especially in Chinese construction in recent years. Carba mix (9.94%), nickel sulfate (7.55%), fragrance mix (7.37%), formaldehyde (6.45%) and cobalt chloride (6.26%), were also common allergens in CU patients in central China, revealing a different sensitization profile compared with Europe. Our study also demonstrated that the positive reaction rate for allergens varied according to gender, age and occupation. Positive reactions to potassium dichromate, benzene mix and carba mix, were more common among men, while nickel sulfate was more frequent among women. Formaldehyde was a common allergen in middle-aged patients, whereas epoxy resin and fragrance mix sensitivity were more frequent among elderly patients. Construction workers presented higher positive reaction rates to potassium dichromate than workers from other occupations, as is the case in other countries.[14-16] We supposed these differences might be due to the different frequencies and durations of contact allergen exposure among CU patients. Determining the relevance of positive reactions from patients upon contact sensitization is pivotal. As mentioned above, the role of contact allergens in CU remains a controversial issue. We divided our CU patients into 2 groups: contact allergen positive and negative. Patients with positive reactions were informed about how to avoid the revealed allergens, with detailed oral and written instructions. Results revealed that symptoms had improved significantly in the positive group - compared with the negative group - after 4 weeks’ observation, suggesting that contact allergens may play a role in the pathogenic mechanism of CU. Moreover, we noticed that some patients’ symptoms subsided dramatically after removing or avoiding contact allergens (e.g. artificial teeth or intrauterine contraceptive rings). However, the exact mechanism by which these allergens cause CU is not yet clear. Since CU is a mast cell-driven disease, we hypothesize that contact allergens can be absorbed into the body and delivered to antigen-presenting cells, leading to mast cell activation. Alternatively, they may activate mast cells directly. Further studies are needed to elucidate the exact mechanism. Our study has some limitations, including the following: (i) not all CU patients who presented to our hospital agreed to undergo patch testing, which may have affected our contact sensitization profiles; (ii) patients included in our intervention study were based on the patch testing results, but not in a randomized manner, though randomizing positive reaction patients into allergen avoidance and control groups is preferable; (iii) the data on CU severity reevaluation were acquired by telephone interview, not via rescheduled follow-up visits to assure patient compliance, while the scores filled out by patients in a print scale directly under the doctors’ guide were considered reliable; and (iv) like other trials, some patients may have had poor compliance, likely influencing the final outcome.

CONCLUSION

Our study outlines the incidence of contact sensitization and distribution profiles in central Chinese subjects CU. Almost half of the CU patients had positive reactions to contact allergens, and allergen avoidance methods can help to relieve CU symptoms. Contact sensitization may play a role in CU, and we suggest that patch testing should be considered in patients with chronic idiopathic urticaria.
  16 in total

1.  Role of contact sensitization in chronic urticaria.

Authors:  Laura Guerra; Anthi Rogkakou; Piera Massacane; Cinzia Gamalero; Enrico Compalati; Cristian Zanella; Antonio Scordamaglia; Walter G Canonica; Giovanni Passalacqua
Journal:  J Am Acad Dermatol       Date:  2006-10-20       Impact factor: 11.527

2.  A new tool to evaluate the impact of chronic urticaria on quality of life: chronic urticaria quality of life questionnaire (CU-QoL).

Authors:  I Baiardini; M Pasquali; F Braido; F Fumagalli; L Guerra; E Compalati; M Braga; C Lombardi; O Fassio; G W Canonica
Journal:  Allergy       Date:  2005-08       Impact factor: 13.146

3.  Methods report on the development of the 2013 revision and update of the EAACI/GA2 LEN/EDF/WAO guideline for the definition, classification, diagnosis, and management of urticaria.

Authors:  T Zuberbier; W Aberer; R Asero; C Bindslev-Jensen; Z Brzoza; G W Canonica; M K Church; L F Ensina; A Giménez-Arnau; K Godse; M Gonçalo; C Grattan; J Hebert; M Hide; A Kaplan; A Kapp; A H Abdul Latiff; P Mathelier-Fusade; M Metz; S S Saini; M Sánchez-Borges; P Schmid-Grendelmeier; F E R Simons; P Staubach; G Sussman; E Toubi; G A Vena; B Wedi; X J Zhu; A Nast; M Maurer
Journal:  Allergy       Date:  2014-07       Impact factor: 13.146

4.  Patch testing and aeroallergen intradermal testing in suspected allergic contact dermatitis, unclassified endogenous eczema and non-atopic chronic urticaria.

Authors:  L F Li; J Wang
Journal:  Contact Dermatitis       Date:  2001-08       Impact factor: 6.600

5.  Chronic urticaria due to nickel intake.

Authors:  D Abeck; I Traenckner; V Steinkraus; D Vieluf; J Ring
Journal:  Acta Derm Venereol       Date:  1993-12       Impact factor: 4.437

6.  Chronic idiopathic urticaria: comparison of the clinical features of patients with and without anti-FcepsilonRI or anti-IgE autoantibodies.

Authors:  R A Sabroe; P T Seed; D M Francis; R M Barr; A K Black; M W Greaves
Journal:  J Am Acad Dermatol       Date:  1999-03       Impact factor: 11.527

7.  Frequency of standard and occupational contact allergens in Tuzla area, Bosnia and Herzegovina: retrospective study.

Authors:  Nerma Sijercić; Nermina Hadzigrahić; Selma Kamberović; Edin Suljagić
Journal:  Acta Dermatovenerol Croat       Date:  2003       Impact factor: 1.256

8.  Prevalence of Helicobacter pylori-associated gastritis in chronic urticaria.

Authors:  B Wedi; S Wagner; T Werfel; M P Manns; A Kapp
Journal:  Int Arch Allergy Immunol       Date:  1998-08       Impact factor: 2.749

9.  Beneficial effects of Helicobacter pylori eradication on idiopathic chronic urticaria.

Authors:  C Di Campli; A Gasbarrini; E Nucera; F Franceschi; V Ojetti; E Sanz Torre; D Schiavino; P Pola; G Patriarca; G Gasbarrini
Journal:  Dig Dis Sci       Date:  1998-06       Impact factor: 3.199

10.  Etiologic aspects of chronic urticaria.

Authors:  M Liutu; K Kalimo; J Uksila; H Kalimo
Journal:  Int J Dermatol       Date:  1998-07       Impact factor: 2.736

View more
  4 in total

1.  Chronic Spontaneous Urticaria: An Etiopathogenic Study.

Authors:  Apoorva Maheshwari; Taru Garg; Ram Chander; Ekta Debnath
Journal:  Indian J Dermatol       Date:  2022 Jan-Feb       Impact factor: 1.757

2.  Role of Patch Testing in Chronic Spontaneous Urticaria.

Authors:  Jonathan Bar; Sari Godlewicz; Arieh Ingber; Eli Sprecher; Dan Slodownik
Journal:  J Asthma Allergy       Date:  2021-08-21

3.  Management of chronic urticaria in children: a clinical guideline.

Authors:  Carlo Caffarelli; Francesco Paravati; Maya El Hachem; Marzia Duse; Marcello Bergamini; Giovanni Simeone; Massimo Barbagallo; Roberto Bernardini; Paolo Bottau; Filomena Bugliaro; Silvia Caimmi; Fernanda Chiera; Giuseppe Crisafulli; Cristiana De Ranieri; Dora Di Mauro; Andrea Diociaiuti; Fabrizio Franceschini; Massimo Gola; Amelia Licari; Lucia Liotti; Carla Mastrorilli; Domenico Minasi; Francesca Mori; Iria Neri; Aurelia Pantaleo; Francesca Saretta; Carlo Filippo Tesi; Giovanni Corsello; Gian Luigi Marseglia; Alberto Villani; Fabio Cardinale
Journal:  Ital J Pediatr       Date:  2019-08-15       Impact factor: 2.638

4.  Prevalence of allergen sensitization among 1,091 patients with urticaria.

Authors:  Jie-Dan Ping; Jun-Wei Zhao; Xiao-Xu Sun; Fan Wu; Zhi-Yun Jiang; Zhe Cheng; Lei Zheng; Hai-Kuo Xue; Jing-Jing Yang; Liang Ming
Journal:  Exp Ther Med       Date:  2019-12-23       Impact factor: 2.447

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.